Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,457 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma.
Hasanov M, Rioth MJ, Kendra K, Hernandez-Aya L, Joseph RW, Williamson S, Chandra S, Shirai K, Turner CD, Lewis K, Crowley E, Moscow J, Carter B, Patel S. Hasanov M, et al. Among authors: patel s. Cancers (Basel). 2020 Aug 13;12(8):2270. doi: 10.3390/cancers12082270. Cancers (Basel). 2020. PMID: 32823698 Free PMC article.
A phase II study of gefitinib in patients with metastatic melanoma.
Patel SP, Kim KB, Papadopoulos NE, Hwu WJ, Hwu P, Prieto VG, Bar-Eli M, Zigler M, Dobroff A, Bronstein Y, Bassett RL, Vardeleon AG, Bedikian AY. Patel SP, et al. Melanoma Res. 2011 Aug;21(4):357-63. doi: 10.1097/CMR.0b013e3283471073. Melanoma Res. 2011. PMID: 21738104 Free PMC article. Clinical Trial.
Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the Liver.
Vera-Aguilera J, Bedikian AY, Bassett RL, Hwu WJ, Kim KB, Qin Y, Cain S, Washington EW, Davies MA, Patel SM, Homsi J, Papadopoulos NE, Hwu P, Patel SP. Vera-Aguilera J, et al. Among authors: patel sp, patel sm. Am J Clin Oncol. 2018 Nov;41(11):1132-1136. doi: 10.1097/COC.0000000000000436. Am J Clin Oncol. 2018. PMID: 29509591 Free PMC article.
Adjuvant Ipilimumab in High-Risk Uveal Melanoma.
Fountain E, Bassett RL, Cain S, Posada L, Gombos DS, Hwu P, Bedikian A, Patel SP. Fountain E, et al. Among authors: patel sp. Cancers (Basel). 2019 Jan 29;11(2):152. doi: 10.3390/cancers11020152. Cancers (Basel). 2019. PMID: 30699934 Free PMC article.
Metastatic Risk Factors Associated with Class 1A Uveal Melanoma Patients.
Ballhausen A, Urias E, Gruschkus SK, Williams M, Glover MS, Qin Y, Gombos DS, Patel SP. Ballhausen A, et al. Among authors: patel sp. Cancers (Basel). 2021 Jun 30;13(13):3292. doi: 10.3390/cancers13133292. Cancers (Basel). 2021. PMID: 34209210 Free PMC article.
An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma.
Hasanov M, Milton DR, Sharfman WH, Taback B, Cranmer LD, Daniels GA, Flaherty L, Hallmeyer S, Milhem M, Feun L, Hauke R, Doolittle G, Gregory N, Patel S. Hasanov M, et al. Among authors: patel s. Oncoimmunology. 2021 Oct 9;10(1):1984059. doi: 10.1080/2162402X.2021.1984059. eCollection 2021. Oncoimmunology. 2021. PMID: 34650833 Free PMC article. Clinical Trial.
Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma.
Grossmann KF, Othus M, Patel SP, Tarhini AA, Sondak VK, Knopp MV, Petrella TM, Truong TG, Khushalani NI, Cohen JV, Buchbinder EI, Kendra K, Funchain P, Lewis KD, Conry RM, Chmielowski B, Kudchadkar RR, Johnson DB, Li H, Moon J, Eroglu Z, Gastman B, Kovacsovics-Bankowski M, Gunturu KS, Ebbinghaus SW, Ahsan S, Ibrahim N, Sharon E, Korde LA, Kirkwood JM, Ribas A. Grossmann KF, et al. Among authors: patel sp. Cancer Discov. 2022 Mar 1;12(3):644-653. doi: 10.1158/2159-8290.CD-21-1141. Cancer Discov. 2022. PMID: 34764195 Free PMC article. Clinical Trial.
Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma: A Secondary Analysis of the SWOG S1404 Randomized Clinical Trial.
Unger JM, Darke A, Othus M, Truong TG, Khushalani N, Kendra K, Lewis KD, Faller B, Funchain P, Buchbinder EI, Tarhini AA, Kirkwood JM, Sharon E, Sondak V, Guild SR, Grossmann K, Ribas A, Patel SP. Unger JM, et al. JAMA Oncol. 2023 Feb 1;9(2):251-260. doi: 10.1001/jamaoncol.2022.5486. JAMA Oncol. 2023. PMID: 36416836 Free PMC article. Clinical Trial.
15,457 results
You have reached the last available page of results. Please see the User Guide for more information.